CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | bromoarene |
|
Accession: | CHEBI:37148
|
browse the term
|
Definition: | A compound derived from an arene by replacing a hydrogen atom with a bromine atom. |
Synonyms: | related_synonym: | aryl bromide; aryl bromides; bromoarenes |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
2,4,5,2',4',5'-hexabromobiphenyl binds to and results in increased activity of AHR protein |
CTD |
PMID:15099731 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
ISO |
[Dieldrin co-treated with 2,4,5,2',4',5'-hexabromobiphenyl] results in decreased expression of GJA1 protein |
CTD |
PMID:8820588 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
decreases expression |
EXP |
bromobenzene results in decreased expression of AACS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
EXP |
bromobenzene results in increased expression of AASS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
EXP |
bromobenzene results in increased expression of ABCB1A mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb7 |
ATP binding cassette subfamily B member 7 |
increases expression |
EXP |
bromobenzene results in increased expression of ABCB7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:69,295,598...69,436,775
Ensembl chr X:69,295,552...69,436,858
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
bromobenzene results in increased expression of ABCC3 mRNA |
CTD |
PMID:17538237 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of ABCC4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ABCC8 mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ABCG2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abhd15 |
abhydrolase domain containing 15 |
increases expression |
EXP |
bromobenzene results in increased expression of ABHD15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:62,363,209...62,368,600
Ensembl chr10:62,363,209...62,368,600
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
increases expression |
EXP |
bromobenzene results in increased expression of ABLIM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:55,256,135...55,376,629
Ensembl chr18:55,257,583...55,376,380
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACAT2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acer2 |
alkaline ceramidase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ACER2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
|
|
G |
Ackr2 |
atypical chemokine receptor 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ACKR2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:121,559,563...121,573,633
Ensembl chr 8:121,561,211...121,573,582
|
|
G |
Acly |
ATP citrate lyase |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACLY mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression |
EXP |
bromobenzene results in increased expression of ACOT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acsbg1 |
acyl-CoA synthetase bubblegum family member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ACSBG1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:54,991,294...55,047,276
Ensembl chr 8:54,991,296...55,047,391
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACSL1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACSL3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACSS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Actb |
actin, beta |
increases expression |
EXP |
bromobenzene results in increased expression of ACTB mRNA |
CTD |
PMID:16036859 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actl7b |
actin-like 7b |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACTL7B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:71,445,532...71,446,920
Ensembl chr 5:71,445,534...71,446,920
|
|
G |
Actn4 |
actinin alpha 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ACTN4 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
|
|
G |
Adamts15 |
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
increases expression |
EXP |
bromobenzene results in increased expression of ADAMTS15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:29,307,864...29,331,249
Ensembl chr 8:29,307,865...29,331,249
|
|
G |
Adamts3 |
ADAM metallopeptidase with thrombospondin type 1, motif 3 |
increases expression |
EXP |
bromobenzene results in increased expression of ADAMTS3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:18,231,128...18,437,771
Ensembl chr14:18,231,165...18,435,556
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ADAMTS7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328
|
|
G |
Adgrf3 |
adhesion G protein-coupled receptor F3 |
increases expression |
EXP |
bromobenzene results in increased expression of ADGRF3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:26,133,176...26,144,601
Ensembl chr 6:26,133,192...26,144,601
|
|
G |
Adgrg3 |
adhesion G protein-coupled receptor G3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ADGRG3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:9,972,425...10,001,118
Ensembl chr19:9,972,430...10,001,123
|
|
G |
Adgrg5 |
adhesion G protein-coupled receptor G5 |
increases expression |
EXP |
bromobenzene results in increased expression of ADGRG5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:10,074,787...10,098,640
Ensembl chr19:10,079,375...10,097,214
|
|
G |
Adm2 |
adrenomedullin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ADM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:120,393,179...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Adora2b |
adenosine A2B receptor |
decreases expression |
EXP |
bromobenzene results in decreased expression of ADORA2B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
decreases expression |
EXP |
bromobenzene results in decreased expression of ADRA2C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:75,470,884...75,472,846
Ensembl chr14:75,471,143...75,472,846
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
EXP |
bromobenzene results in increased expression of AHR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aim2 |
absent in melanoma 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of AIM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:85,865,206...85,906,996
Ensembl chr13:85,866,284...85,906,975
|
|
G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of AIP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:201,408,002...201,419,220
Ensembl chr 1:201,407,288...201,419,122
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
bromobenzene results in increased expression of AKR7A3 mRNA |
CTD |
PMID:12628495 PMID:15056800 PMID:32479839 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Alad |
aminolevulinate dehydratase |
decreases activity decreases expression multiple interactions |
ISO EXP |
bromobenzene results in decreased activity of ALAD protein bromobenzene results in decreased expression of ALAD mRNA [Phenobarbital co-treated with bromobenzene] results in decreased activity of ALAD protein; Carbon Monoxide inhibits the reaction [[Phenobarbital co-treated with bromobenzene] results in decreased activity of ALAD protein] |
CTD |
PMID:6740708 PMID:16140629 PMID:32479839 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alb |
albumin |
increases expression affects binding |
EXP |
bromobenzene results in increased expression of ALB mRNA bromobenzene metabolite binds to ALB protein |
CTD |
PMID:12018992 PMID:17305373 PMID:23288050 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects binding increases expression |
EXP |
bromobenzene metabolite binds to ALDH1A1 protein bromobenzene results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:12628495 PMID:17305373 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects binding |
EXP |
bromobenzene metabolite binds to ALDH2 protein |
CTD |
PMID:17305373 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
affects binding |
EXP |
bromobenzene metabolite binds to ALDH9A1 protein |
CTD |
PMID:17305373 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
increases expression |
EXP |
bromobenzene results in increased expression of ALOX15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Als2cl |
ALS2 C-terminal like |
increases expression |
EXP |
bromobenzene results in increased expression of ALS2CL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
increases expression |
EXP |
bromobenzene results in increased expression of AMBP mRNA |
CTD |
PMID:23288050 |
|
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
|
|
G |
Angptl1 |
angiopoietin-like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ANGPTL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:68,963,186...68,981,649
Ensembl chr13:68,962,991...68,992,570
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
EXP |
bromobenzene results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Angptl8 |
angiopoietin-like 8 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ANGPTL8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:20,376,462...20,378,488
Ensembl chr 8:20,376,462...20,378,490
|
|
G |
Ankle1 |
ankyrin repeat and LEM domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ANKLE1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:18,076,413...18,082,356
Ensembl chr16:18,076,492...18,083,729
|
|
G |
Ankmy1 |
ankyrin repeat and MYND domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ANKMY1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:93,423,664...93,476,651
Ensembl chr 9:93,423,963...93,477,236
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ANKRD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Ankrd13d |
ankyrin repeat domain 13D |
increases expression |
EXP |
bromobenzene results in increased expression of ANKRD13D mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:201,565,712...201,577,987
Ensembl chr 1:201,565,712...201,577,933
|
|
G |
Ankrd33b |
ankyrin repeat domain 33B |
increases expression |
EXP |
bromobenzene results in increased expression of ANKRD33B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:82,277,604...82,359,420
Ensembl chr 2:82,283,108...82,358,872
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
EXP |
bromobenzene results in increased expression of ANLN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Anxa13 |
annexin A13 |
increases expression |
EXP |
bromobenzene results in increased expression of ANXA13 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
increases expression |
EXP |
bromobenzene results in increased expression of APC mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apoc3 |
apolipoprotein C3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of APOC3 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
|
|
G |
Apoh |
apolipoprotein H |
increases expression |
EXP |
bromobenzene results in increased expression of APOH mRNA |
CTD |
PMID:23288050 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of APOLD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
|
|
G |
Apom |
apolipoprotein M |
increases expression |
EXP |
bromobenzene results in increased expression of APOM mRNA |
CTD |
PMID:12628495 |
|
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
|
|
G |
Aptx |
aprataxin |
decreases expression |
EXP |
bromobenzene results in decreased expression of APTX mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:55,798,896...55,822,963
Ensembl chr 5:55,800,248...55,822,855
|
|
G |
Arg1 |
arginase 1 |
affects binding increases expression |
EXP |
bromobenzene metabolite binds to ARG1 protein bromobenzene results in increased expression of ARG1 mRNA |
CTD |
PMID:17305373 PMID:32479839 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arhgap19 |
Rho GTPase activating protein 19 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ARHGAP19 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:240,571,554...240,617,361
Ensembl chr 1:240,580,871...240,617,287
|
|
G |
Arhgap32 |
Rho GTPase activating protein 32 |
increases expression |
EXP |
bromobenzene results in increased expression of ARHGAP32 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:30,421,269...30,681,653
Ensembl chr 8:30,421,515...30,678,454
|
|
G |
Arhgef19 |
Rho guanine nucleotide exchange factor 19 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ARHGEF19 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:153,536,038...153,554,203
Ensembl chr 5:153,536,013...153,554,203
|
|
G |
Arid5a |
AT-rich interaction domain 5A |
increases expression |
EXP |
bromobenzene results in increased expression of ARID5A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
|
|
G |
Armc7 |
armadillo repeat containing 7 |
increases expression |
EXP |
bromobenzene results in increased expression of ARMC7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:100,723,080...100,739,636
Ensembl chr10:100,723,105...100,739,636
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ASB4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:33,506,992...33,544,630
Ensembl chr 4:33,506,992...33,544,630
|
|
G |
Asf1a |
anti-silencing function 1A histone chaperone |
increases expression |
EXP |
bromobenzene results in increased expression of ASF1A mRNA |
CTD |
PMID:12628495 |
|
NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808
|
|
G |
Asl |
argininosuccinate lyase |
increases expression |
EXP |
bromobenzene results in increased expression of ASL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Atp12a |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
increases expression |
EXP |
bromobenzene results in increased expression of ATP12A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ATP1B1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
increases expression |
EXP |
bromobenzene results in increased expression of ATP6V0D2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression |
EXP |
bromobenzene results in increased expression of ATP6V1C2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
affects expression |
EXP |
bromobenzene affects the expression of AVPR1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
increases expression |
EXP |
bromobenzene results in increased expression of B3GALNT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
EXP |
bromobenzene results in decreased expression of BAAT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
increases expression |
EXP |
bromobenzene results in increased expression of BACH1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Banp |
Btg3 associated nuclear protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of BANP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:50,007,710...50,082,742
Ensembl chr19:50,007,881...50,082,738
|
|
G |
Bex1 |
brain expressed X-linked 1 |
increases expression |
EXP |
bromobenzene results in increased expression of BEX2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
|
|
G |
Bhlha15 |
basic helix-loop-helix family, member a15 |
decreases expression |
EXP |
bromobenzene results in decreased expression of BHLHA15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:10,420,465...10,424,641
Ensembl chr12:10,420,467...10,424,713
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
decreases expression |
EXP |
bromobenzene results in decreased expression of BHLHE40 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression increases expression |
EXP |
bromobenzene results in decreased expression of BHMT mRNA bromobenzene results in increased expression of BHMT mRNA |
CTD |
PMID:12628495 PMID:15056800 PMID:32479839 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of BMAL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmal2 |
basic helix-loop-helix ARNT like 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of BMAL2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:179,699,432...179,747,710
Ensembl chr 4:179,699,502...179,746,949
|
|
G |
Bmf |
Bcl2 modifying factor |
decreases expression |
EXP |
bromobenzene results in decreased expression of BMF mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Brinp2 |
BMP/retinoic acid inducible neural specific 2 |
increases expression |
EXP |
bromobenzene results in increased expression of BRINP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:70,431,006...70,532,766
Ensembl chr13:70,431,010...70,531,810
|
|
G |
Btbd19 |
BTB domain containing 19 |
increases expression |
EXP |
bromobenzene results in increased expression of BTBD19 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:130,596,966...130,605,403
Ensembl chr 5:130,597,684...130,604,335
|
|
G |
C14h2orf73 |
similar to human chromosome 2 open reading frame 73 |
increases expression |
EXP |
bromobenzene results in increased expression of C14H2ORF73 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:104,145,818...104,178,973
Ensembl chr14:104,145,818...104,178,973
|
|
G |
C1qtnf7 |
C1q and TNF related 7 |
increases expression |
EXP |
bromobenzene results in increased expression of C1QTNF7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:67,467,888...67,580,477
Ensembl chr14:67,468,014...67,580,410
|
|
G |
C1r |
complement C1r |
decreases expression |
EXP |
bromobenzene results in decreased expression of C1R mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
affects binding |
EXP |
bromobenzene metabolite binds to C8H11ORF54 protein |
CTD |
PMID:17305373 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
C8h15orf39 |
similar to human chromosome 15 open reading frame 39 |
increases expression |
EXP |
bromobenzene results in increased expression of C8H15ORF39 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
|
|
G |
C9 |
complement C9 |
decreases expression |
EXP |
bromobenzene results in decreased expression of C9 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
Calml3 |
calmodulin-like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of CALML3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175
|
|
G |
Capn1 |
calpain 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CAPN1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CAR1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car12 |
carbonic anhydrase 12 |
increases expression |
EXP |
bromobenzene results in increased expression of CA12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car2 |
carbonic anhydrase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CAR2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car3 |
carbonic anhydrase 3 |
affects binding decreases expression |
EXP |
bromobenzene metabolite binds to CA3 protein bromobenzene results in decreased expression of CA3 mRNA |
CTD |
PMID:17305373 PMID:32479839 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Card19 |
caspase recruitment domain family, member 19 |
increases expression |
EXP |
bromobenzene results in increased expression of CARD19 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:15,432,632...15,445,317
Ensembl chr17:15,432,612...15,445,318
|
|
G |
Cblc |
Cbl proto-oncogene C |
decreases expression |
EXP |
bromobenzene results in decreased expression of CBLC mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:79,439,975...79,456,755
Ensembl chr 1:79,439,977...79,456,755
|
|
G |
Ccdc106 |
coiled-coil domain containing 106 |
increases expression |
EXP |
bromobenzene results in increased expression of CCDC106 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:68,779,882...68,783,975
Ensembl chr 1:68,779,882...68,786,846
|
|
G |
Ccdc122 |
coiled-coil domain containing 122 |
increases expression |
EXP |
bromobenzene results in increased expression of CCDC122 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:52,407,717...52,470,163
Ensembl chr15:52,407,717...52,470,163
|
|
G |
Ccdc96 |
coiled-coil domain containing 96 |
increases expression |
EXP |
bromobenzene results in increased expression of CCDC96 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:74,276,568...74,279,072
Ensembl chr14:74,276,960...74,278,888
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CCL7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CCN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CCND1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CCNE1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccser2 |
coiled-coil serine-rich protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CCSER2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738
|
|
G |
Cd274 |
CD274 molecule |
decreases expression |
EXP |
bromobenzene results in decreased expression of CD274 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd3e |
CD3 epsilon subunit of T-cell receptor complex |
increases expression |
EXP |
bromobenzene results in increased expression of CD3E mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022
|
|
G |
Cd99l2 |
CD99 molecule-like 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CD99L2 mRNA |
CTD |
PMID:32479839 |
|
|
|
G |
Cdc34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
increases expression |
EXP |
bromobenzene results in increased expression of CDC34 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
|
|
G |
Cdh10 |
cadherin 10 |
increases expression |
EXP |
bromobenzene results in increased expression of CDH10 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:68,628,623...68,850,995
Ensembl chr 2:68,628,780...68,850,995
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
bromobenzene results in increased expression of CDKN1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression increases expression |
EXP |
bromobenzene results in decreased expression of CDO1 mRNA bromobenzene results in increased expression of CDO1 mRNA |
CTD |
PMID:12628495 PMID:15056800 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Cds2 |
CDP-diacylglycerol synthase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CDS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:119,514,963...119,553,555
Ensembl chr 3:119,515,000...119,553,541
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CDT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
decreases expression |
EXP |
bromobenzene results in decreased expression of CEBPD mRNA |
CTD |
PMID:12628495 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Cemip |
cell migration inducing hyaluronidase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CEMIP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415
|
|
G |
Cenpk |
centromere protein K |
decreases expression |
EXP |
bromobenzene results in decreased expression of CENPK mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
|
|
G |
Cenpt |
centromere protein T |
increases expression |
EXP |
bromobenzene results in increased expression of CENPT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:33,734,684...33,741,159
Ensembl chr19:33,734,685...33,741,142
|
|
G |
Cenpw |
centromere protein W |
increases expression |
EXP |
bromobenzene results in increased expression of CENPW mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
|
|
G |
Cfap95 |
cilia and flagella associated protein 95 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CFAP95 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:221,123,786...221,242,963
Ensembl chr 1:221,131,813...221,242,963
|
|
G |
Cfl1 |
cofilin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CFL1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CHAC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chmp4c |
charged multivesicular body protein 4C |
increases expression |
EXP |
bromobenzene results in increased expression of CHMP4C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668
|
|
G |
Chrdl1 |
chordin-like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CHRDL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
|
|
G |
Chrna1 |
cholinergic receptor nicotinic alpha 1 subunit |
increases expression |
EXP |
bromobenzene results in increased expression of CHRNA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:58,454,763...58,469,832
Ensembl chr 3:58,454,744...58,469,840
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
increases expression |
EXP |
bromobenzene results in increased expression of CHRNA5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Ciart |
circadian associated repressor of transcription |
decreases expression |
EXP |
bromobenzene results in decreased expression of CIART mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:183,419,819...183,424,845
Ensembl chr 2:183,419,819...183,423,313
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
affects expression |
EXP |
bromobenzene affects the expression of CITED4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:134,246,936...134,247,827
Ensembl chr 5:134,246,682...134,248,135
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CLCF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn1 |
claudin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CLDN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn3 |
claudin 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CLDN3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Clec2dl1 |
C-type lectin domain family 2 member D-like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CLEC2DL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:162,263,635...162,274,882
Ensembl chr 4:162,263,639...162,274,880
|
|
G |
Clock |
clock circadian regulator |
increases expression |
EXP |
bromobenzene results in increased expression of CLOCK mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
|
|
G |
Clspn |
claspin |
decreases expression |
EXP |
bromobenzene results in decreased expression of CLSPN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
|
|
G |
Clstn3 |
calsyntenin 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CLSTN3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769
|
|
G |
Cltb |
clathrin, light chain B |
increases expression |
EXP |
bromobenzene results in increased expression of CLTB mRNA |
CTD |
PMID:12628495 |
|
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
|
|
G |
Cntnap4 |
contactin associated protein family member 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CNTNAP4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:40,568,684...40,861,879
Ensembl chr19:40,568,684...40,854,656
|
|
G |
Colq |
collagen like tail subunit of asymmetric acetylcholinesterase |
increases expression |
EXP |
bromobenzene results in increased expression of COLQ mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
|
|
G |
Coq10b |
coenzyme Q10B |
affects expression |
EXP |
bromobenzene affects the expression of COQ10B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
|
|
G |
Coro6 |
coronin 6 |
increases expression |
EXP |
bromobenzene results in increased expression of CORO6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CPEB2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:67,787,503...67,839,973
Ensembl chr14:67,787,507...67,840,743
|
|
G |
Cpne1 |
copine 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CPNE1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
|
|
G |
Crat |
carnitine O-acetyltransferase |
increases expression |
EXP |
bromobenzene results in increased expression of CRAT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of CREB3L3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CREG1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
|
|
G |
Crmp1 |
collapsin response mediator protein 1 |
affects expression |
EXP |
bromobenzene affects the expression of CRMP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:73,509,933...73,556,192
Ensembl chr14:73,509,933...73,556,177
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CRY1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cryga |
crystallin, gamma A |
decreases expression |
EXP |
bromobenzene results in decreased expression of CRYGA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:66,482,176...66,484,638
Ensembl chr 9:66,482,176...66,509,896
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
increases expression |
EXP |
bromobenzene results in increased expression of CSAD mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CSMD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614
|
|
G |
Csnk2b |
casein kinase 2 beta |
increases expression |
EXP |
bromobenzene results in increased expression of CSNK2B mRNA |
CTD |
PMID:16036859 |
|
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Ctsl |
cathepsin L |
increases expression |
EXP |
bromobenzene results in increased expression of CTSL mRNA |
CTD |
PMID:12628495 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Cux2 |
cut-like homeobox 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CUX2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CXCL13 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxcr6 |
C-X-C motif chemokine receptor 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CXCR6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:123,434,417...123,439,568
Ensembl chr 8:123,416,325...123,439,526
|
|
G |
Cyb5a |
cytochrome b5 type A |
increases expression |
EXP |
bromobenzene results in increased expression of CYB5A mRNA |
CTD |
PMID:12628495 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
EXP |
bromobenzene results in increased expression of CYCS mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP17A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
affects expression |
EXP |
bromobenzene affects the expression of CYP1A1 protein |
CTD |
PMID:10445401 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP26A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP27B1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP2B2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP2C12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:238,699,859...238,757,011
Ensembl chr 1:238,699,854...238,757,019
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP2E1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CYP3A9 mRNA |
CTD |
PMID:17538237 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP4A3 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
EXP |
bromobenzene results in decreased expression of CYP51 mRNA |
CTD |
PMID:12628495 PMID:32479839 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of CYP7A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
affects expression |
EXP |
bromobenzene affects the expression of CYP8B1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
decreases expression |
EXP |
bromobenzene results in decreased expression of DBP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DDIT3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddt |
D-dopachrome tautomerase |
affects binding |
EXP |
bromobenzene metabolite binds to DDT protein |
CTD |
PMID:17305373 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
increases expression |
EXP |
bromobenzene results in increased expression of DEPP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
|
|
G |
Derl3 |
derlin 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DERL3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
decreases expression |
EXP |
bromobenzene results in decreased expression of DHCR7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhx40 |
DEAH-box helicase 40 |
increases expression |
EXP |
bromobenzene results in increased expression of DHX40 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:71,584,546...71,621,479
Ensembl chr10:71,583,716...71,621,445
|
|
G |
Dipk1c |
divergent protein kinase domain 1C |
increases expression |
EXP |
bromobenzene results in increased expression of DIPK1C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:78,087,972...78,109,910
Ensembl chr18:78,087,991...78,109,904
|
|
G |
Disp1 |
dispatched RND transporter family member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of DISP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:94,720,928...94,866,695
Ensembl chr13:94,720,928...94,866,702
|
|
G |
Dlgap5 |
DLG associated protein 5 |
increases expression |
EXP |
bromobenzene results in increased expression of DLGAP5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dmtn |
dematin actin binding protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of DMTN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:45,677,974...45,702,261
Ensembl chr15:45,677,977...45,705,601
|
|
G |
Dnah17 |
dynein, axonemal, heavy chain 17 |
increases expression |
EXP |
bromobenzene results in increased expression of DNAH17 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:103,244,144...103,364,953
Ensembl chr10:103,249,363...103,364,901
|
|
G |
Dnase1l2 |
deoxyribonuclease 1 like 2 |
increases expression |
EXP |
bromobenzene results in increased expression of DNASE1L2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:13,471,850...13,473,447
Ensembl chr10:13,471,479...13,473,763
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
increases expression |
EXP |
bromobenzene results in increased expression of DNMT3B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dok7 |
docking protein 7 |
increases expression |
EXP |
bromobenzene results in increased expression of DOK7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:75,665,444...75,699,413
Ensembl chr14:75,666,744...75,699,386
|
|
G |
Dpp6 |
dipeptidyl peptidase like 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DPP6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:7,589,386...8,508,666
Ensembl chr 4:7,591,009...8,508,532
|
|
G |
Dr1 |
down-regulator of transcription 1 |
increases expression |
EXP |
bromobenzene results in increased expression of DR1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:1,458,223...1,469,578
Ensembl chr14:1,458,223...1,469,638
|
|
G |
Dsc2 |
desmocollin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of DSC2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dtx3 |
deltex E3 ubiquitin ligase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of DTX3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:63,013,769...63,018,431
Ensembl chr 7:63,013,371...63,018,522
|
|
G |
Duoxa1 |
dual oxidase maturation factor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DUOXA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:109,249,815...109,260,511
Ensembl chr 3:109,249,923...109,260,499
|
|
G |
Dus4l |
dihydrouridine synthase 4-like |
increases expression |
EXP |
bromobenzene results in increased expression of DUS4L mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of DUSP6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
increases expression |
EXP |
bromobenzene results in increased expression of DUSP8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
|
|
G |
Dynlt4 |
dynein light chain Tctex-type 4 |
increases expression |
EXP |
bromobenzene results in increased expression of DYNLT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:130,605,437...130,607,224
Ensembl chr 5:130,605,399...130,607,666
|
|
G |
E2f7 |
E2F transcription factor 7 |
increases expression |
EXP |
bromobenzene results in increased expression of E2F7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ECI1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ECM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
|
|
G |
Edar |
ectodysplasin-A receptor |
decreases expression |
EXP |
bromobenzene results in decreased expression of EDAR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:26,587,836...26,666,543
Ensembl chr20:26,587,839...26,666,494
|
|
G |
Eea1 |
early endosome antigen 1 |
increases expression |
EXP |
bromobenzene results in increased expression of EEA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:30,554,686...30,722,186
Ensembl chr 7:30,554,552...30,718,487
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
multiple interactions |
EXP |
[bromobenzene co-treated with EGLN1 mutant form] results in increased expression of HIF1A protein; [bromobenzene co-treated with EGLN1 mutant form] results in increased expression of HMOX1 mRNA; [bromobenzene co-treated with EGLN1 mutant form] results in increased expression of PTGS2 mRNA |
CTD |
PMID:24190904 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
increases expression |
EXP |
bromobenzene results in increased expression of EIF3C mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:181,134,604...181,152,489
Ensembl chr 1:181,134,604...181,152,493
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
increases expression |
EXP |
bromobenzene results in increased expression of EIF5A mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Eno1 |
enolase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to ENO1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Enpp7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ENPP7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:104,242,169...104,247,185
Ensembl chr10:104,242,223...104,246,589
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of EPHX1 mRNA |
CTD |
PMID:12628495 PMID:17538237 PMID:32479839 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epop |
elongin BC and polycomb repressive complex 2 associated protein |
increases expression |
EXP |
bromobenzene results in increased expression of EPOP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:82,624,392...82,625,912
Ensembl chr10:82,624,392...82,625,912
|
|
G |
Eps8l3 |
EPS8 like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of EPS8L3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:195,514,692...195,528,085
Ensembl chr 2:195,514,692...195,528,085
|
|
G |
Erich5 |
glutamate-rich 5 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ERICH5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:65,655,829...65,682,221
Ensembl chr 7:65,657,204...65,680,207
|
|
G |
Ero1b |
endoplasmic reticulum oxidoreductase 1 beta |
increases expression |
EXP |
bromobenzene results in increased expression of ERO1B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:85,861,086...86,003,244
Ensembl chr17:85,929,618...86,003,398
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
affects binding |
EXP |
bromobenzene metabolite binds to ERP29 protein |
CTD |
PMID:12018992 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Etnppl |
ethanolamine-phosphate phospho-lyase |
increases expression |
EXP |
bromobenzene results in increased expression of ETNPPL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:219,173,048...219,194,646
Ensembl chr 2:219,172,978...219,192,212
|
|
G |
Eva1c |
eva-1 homolog C |
increases expression |
EXP |
bromobenzene results in increased expression of EVA1C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:30,089,510...30,163,596
Ensembl chr11:30,089,365...30,163,596
|
|
G |
F12 |
coagulation factor XII |
increases expression |
EXP |
bromobenzene results in increased expression of F12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:9,207,683...9,215,530
Ensembl chr17:9,207,683...9,215,530
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
decreases expression affects binding |
EXP |
bromobenzene results in decreased expression of FABP1 mRNA bromobenzene metabolite binds to FABP1 protein |
CTD |
PMID:12628495 PMID:17305373 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G |
Fabp12 |
fatty acid binding protein 12 |
increases expression |
EXP |
bromobenzene results in increased expression of FABP12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:91,539,568...91,554,999
Ensembl chr 2:91,500,539...91,554,996
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
affects binding |
EXP |
bromobenzene metabolite binds to FABP7 protein |
CTD |
PMID:17305373 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FADS1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FADS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fah |
fumarylacetoacetate hydrolase |
affects binding |
EXP |
bromobenzene metabolite binds to FAH protein |
CTD |
PMID:17305373 |
|
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
|
|
G |
Fam180a |
family with sequence similarity 180, member A |
increases expression |
EXP |
bromobenzene results in increased expression of FAM180A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:63,992,867...64,008,047
Ensembl chr 4:63,992,867...64,008,047
|
|
G |
Fam222a |
family with sequence similarity 222, member A |
increases expression |
EXP |
bromobenzene results in increased expression of FAM222A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:41,982,064...42,033,085
Ensembl chr12:41,986,780...42,033,682
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
increases expression |
EXP |
bromobenzene results in increased expression of FAM83D mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fam83f |
family with sequence similarity 83, member F |
increases expression |
EXP |
bromobenzene results in increased expression of FAM83F mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:112,211,164...112,240,454
Ensembl chr 7:112,211,164...112,240,452
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
decreases expression |
EXP |
bromobenzene results in decreased expression of FAM89A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
EXP |
bromobenzene results in decreased expression of FASN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of FBN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Fbxo30 |
F-box protein 30 |
increases expression |
EXP |
bromobenzene results in increased expression of FBXO30 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
|
|
G |
Fcamr |
Fc alpha and mu receptor |
increases expression |
EXP |
bromobenzene results in increased expression of FCAMR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:42,273,891...42,288,002
Ensembl chr13:42,273,628...42,287,113
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FDFT1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases expression |
EXP |
bromobenzene results in decreased expression of FDPS mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FEN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
increases expression |
EXP |
bromobenzene results in increased expression of FGF21 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
EXP |
bromobenzene results in decreased expression of FGG mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fgl1 |
fibrinogen-like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FGL1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
bromobenzene results in decreased expression of FGR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
|
|
G |
Fibin |
fin bud initiation factor homolog |
increases expression |
EXP |
bromobenzene results in increased expression of FIBIN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
increases expression |
EXP |
bromobenzene results in increased expression of FKBP5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Flii |
FLII, actin remodeling protein |
increases expression |
EXP |
bromobenzene results in increased expression of FLII mRNA |
CTD |
PMID:12628495 PMID:16036859 |
|
NCBI chr10:45,394,032...45,408,051
Ensembl chr10:45,394,032...45,407,970
|
|
G |
Flnb |
filamin B |
increases expression |
EXP |
bromobenzene results in increased expression of FLNB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
|
|
G |
Flvcr2 |
FLVCR choline and putative heme transporter 2 |
increases expression |
EXP |
bromobenzene results in increased expression of FLVCR2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:105,408,355...105,472,355
Ensembl chr 6:105,408,339...105,472,353
|
|
G |
Fmnl1 |
formin-like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FMNL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:88,115,876...88,143,342
Ensembl chr10:88,116,009...88,143,357
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of FMO1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of FMO2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of FMO3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of FN1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fndc1 |
fibronectin type III domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of FNDC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:47,281,839...47,364,247
Ensembl chr 1:47,281,844...47,364,259
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
decreases expression |
EXP |
bromobenzene results in decreased expression of FOSL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fstl3 |
follistatin like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of FSTL3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,923,574...9,929,223
Ensembl chr 7:9,923,576...9,939,639
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
EXP |
bromobenzene results in increased expression of FTH1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fut1 |
fucosyltransferase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of FUT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
|
|
G |
Fzd7 |
frizzled class receptor 7 |
increases expression |
EXP |
bromobenzene results in increased expression of FZD7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
EXP |
bromobenzene results in increased expression of G6PDX mRNA |
CTD |
PMID:12628495 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gad2 |
glutamate decarboxylase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of GAD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
EXP |
bromobenzene results in increased expression of GADD45A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
EXP |
bromobenzene results in increased expression of GADD45B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
decreases expression |
EXP |
bromobenzene results in decreased expression of GADD45G mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GAL3ST1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388
|
|
G |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GALNT2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:52,213,226...52,324,816
Ensembl chr19:52,213,351...52,324,813
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
affects binding |
EXP |
bromobenzene metabolite binds to GAMT protein |
CTD |
PMID:17305373 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gast |
gastrin |
decreases expression |
EXP |
bromobenzene results in decreased expression of GAST mRNA |
CTD |
PMID:15976192 |
|
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Gba3 |
glucosylceramidase beta 3 |
increases expression |
EXP |
bromobenzene results in increased expression of GBA3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:60,574,974...60,721,411
Ensembl chr14:60,574,976...60,721,653
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GBP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gbp3 |
guanylate binding protein 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GBP3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:231,460,032...231,500,266
Ensembl chr 2:231,486,062...231,493,098
|
|
G |
Gc |
GC, vitamin D binding protein |
increases expression |
EXP |
bromobenzene results in increased expression of GC mRNA |
CTD |
PMID:15056800 PMID:23288050 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
bromobenzene results in increased expression of GCLC protein |
CTD |
PMID:18078705 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
EXP |
bromobenzene results in increased expression of GCLM mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
EXP |
bromobenzene results in increased expression of GDF15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
increases expression |
EXP |
bromobenzene results in increased expression of GEM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
|
|
G |
Gfm1 |
G elongation factor, mitochondrial 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GFM1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
|
|
G |
Ghrhr |
growth hormone releasing hormone receptor |
decreases response to substance |
ISO |
GHRHR gene mutant form results in decreased susceptibility to bromobenzene |
CTD |
PMID:17521389 |
|
NCBI chr 4:84,498,159...84,532,851
Ensembl chr 4:84,500,212...84,532,776
|
|
G |
Gimd1 |
GIMAP family P-loop NTPase domain containing 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GIMD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:221,103,878...221,138,559
Ensembl chr 2:221,103,878...221,138,553
|
|
G |
Gja4 |
gap junction protein, alpha 4 |
increases expression |
EXP |
bromobenzene results in increased expression of GJA4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
EXP |
bromobenzene results in increased expression of GJB2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gli3 |
GLI family zinc finger 3 |
increases expression |
EXP |
bromobenzene results in increased expression of GLI3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
increases activity |
EXP |
bromobenzene results in increased activity of GLUD1 protein |
CTD |
PMID:3012827 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Gnat1 |
G protein subunit alpha transducin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GNAT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671
|
|
G |
Gnmt |
glycine N-methyltransferase |
affects binding |
EXP |
bromobenzene metabolite binds to GNMT protein |
CTD |
PMID:17305373 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GOT1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of GPAT3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gpatch4 |
G patch domain containing 4 |
increases expression |
EXP |
bromobenzene results in increased expression of GPATCH4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:173,499,700...173,520,346
Ensembl chr 2:173,509,897...173,518,684
|
|
G |
Gpbp1l1 |
GC-rich promoter binding protein 1-like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of GPBP1L1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:130,009,768...130,050,636
Ensembl chr 5:130,023,137...130,050,459
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to GPD1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gpr21 |
G protein-coupled receptor 21 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GPR21 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:21,275,289...21,279,008
Ensembl chr 3:21,275,007...21,277,930
|
|
G |
Gpr39 |
G protein-coupled receptor 39 |
increases expression |
EXP |
bromobenzene results in increased expression of GPR39 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:37,115,258...37,327,312
Ensembl chr13:37,115,102...37,328,267
|
|
G |
Gpr65 |
G-protein coupled receptor 65 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GPR65 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:117,515,786...117,536,514
Ensembl chr 6:117,515,648...117,536,512
|
|
G |
Gprin3 |
GPRIN family member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GPRIN3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:88,572,062...88,657,369
Ensembl chr 4:88,563,607...88,657,429
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions increases activity |
ISO EXP |
diisopropyl 1,3-dithiol-2-ylidenemalonate inhibits the reaction [bromobenzene results in increased activity of GPT protein] |
CTD |
PMID:3795300 PMID:32479839 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GPX1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of GPX2 mRNA |
CTD |
PMID:17538237 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
EXP |
bromobenzene results in increased expression of GSTA2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
bromobenzene results in increased expression of GSTA5 mRNA |
CTD |
PMID:17538237 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression affects binding |
EXP |
bromobenzene results in increased expression of GSTM1 mRNA bromobenzene metabolite binds to GSTM1 protein |
CTD |
PMID:12628495 PMID:17305373 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
affects binding |
EXP |
bromobenzene metabolite binds to GSTM2 protein |
CTD |
PMID:17305373 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp3 |
glutathione S-transferase pi 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GSTP3 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr 1:201,355,682...201,358,216
Ensembl chr 1:201,355,682...201,358,330
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GSTT1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gucy1b2 |
guanylate cyclase 1 soluble subunit beta 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of GUCY1B2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:36,589,501...36,669,441
Ensembl chr15:36,598,883...36,669,441
|
|
G |
Gzma |
granzyme A |
decreases expression |
EXP |
bromobenzene results in decreased expression of GZMA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
decreases expression |
EXP |
bromobenzene results in decreased expression of HAMP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HAO2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HBA-A1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hbb |
hemoglobin subunit beta |
affects binding |
EXP |
bromobenzene metabolite binds to HBB protein |
CTD |
PMID:17305373 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
EXP |
bromobenzene results in increased expression of HBEGF mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hemgn |
hemogen |
increases expression |
EXP |
bromobenzene results in increased expression of HEMGN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:60,679,633...60,698,597
Ensembl chr 5:60,679,633...60,698,669
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HES6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
|
|
G |
Hhip |
Hedgehog-interacting protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of HHIP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
[bromobenzene co-treated with EGLN1 mutant form] results in increased expression of HIF1A protein |
CTD |
PMID:24190904 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hif3a |
hypoxia inducible factor 3 subunit alpha |
increases expression |
EXP |
bromobenzene results in increased expression of HIF3A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
|
|
G |
Hjurp |
Holliday junction recognition protein |
increases expression |
EXP |
bromobenzene results in increased expression of HJURP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:88,853,379...88,867,730
Ensembl chr 9:88,853,386...88,867,728
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
increases expression |
EXP |
bromobenzene results in increased expression of HJV mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850
|
|
G |
Hk3 |
hexokinase 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HK3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,599,865...9,614,863
|
|
G |
Hlf |
HLF transcription factor, PAR bZIP family member |
decreases expression |
EXP |
bromobenzene results in decreased expression of HLF mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
increases expression |
EXP |
bromobenzene results in increased expression of HMGN5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
bromobenzene results in increased expression of HMOX1 protein [bromobenzene co-treated with EGLN1 mutant form] results in increased expression of HMOX1 mRNA bromobenzene results in increased expression of HMOX1 mRNA; bromobenzene results in increased expression of HMOX1 protein |
CTD |
PMID:3343248 PMID:12628495 PMID:15056800 PMID:15976192 PMID:18078705 PMID:24190904 PMID:32479839 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
increases expression |
EXP |
bromobenzene results in increased expression of HNF4A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Homer2 |
homer scaffold protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of HOMER2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:135,558,977...135,659,780
Ensembl chr 1:135,567,414...135,659,772
|
|
G |
Hpdl |
4-hydroxyphenylpyruvate dioxygenase-like |
increases expression |
EXP |
bromobenzene results in increased expression of HPDL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:130,286,627...130,288,233
Ensembl chr 5:130,286,631...130,288,233
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
decreases expression |
EXP |
bromobenzene results in decreased expression of HSD17B7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
bromobenzene results in increased expression of HSPA1A mRNA; bromobenzene results in increased expression of HSPA1A protein |
CTD |
PMID:8917683 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
EXP |
bromobenzene results in increased expression of HSPA1B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa4l |
heat shock protein family A (Hsp70) member 4 like |
decreases expression |
EXP |
bromobenzene results in decreased expression of HSPA4L mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression affects binding increases expression |
EXP |
bromobenzene results in decreased expression of HSPA5 mRNA bromobenzene metabolite binds to HSPA5 protein bromobenzene results in increased expression of HSPA5 mRNA |
CTD |
PMID:12018992 PMID:12628495 PMID:15056800 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
affects binding |
EXP |
bromobenzene metabolite binds to HSPA8 protein |
CTD |
PMID:17305373 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of HTATIP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
bromobenzene analog results in increased expression of ICAM1 protein |
CTD |
PMID:19427879 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
increases expression |
EXP |
bromobenzene results in increased expression of ID2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
affects binding |
EXP |
bromobenzene metabolite binds to IDH1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IDI1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
EXP |
bromobenzene results in increased expression of IER3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi27l2a |
interferon, alpha-inducible protein 27 like 2A |
decreases expression |
EXP |
bromobenzene results in decreased expression of ISG12(B) mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:122,598,872...122,600,360
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
increases expression |
EXP |
bromobenzene results in increased expression of IFRD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Ift122 |
intraflagellar transport 122 |
increases expression |
EXP |
bromobenzene results in increased expression of IFT122 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:148,905,031...148,975,458
Ensembl chr 4:148,905,046...148,975,458
|
|
G |
Igdcc3 |
immunoglobulin superfamily, DCC subclass, member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IGDCC3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:65,661,165...65,707,961
Ensembl chr 8:65,661,196...65,707,959
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IGF1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of IGFBP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igsf7l1 |
immunoglobulin superfamily, member 7 like 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IGSF7L1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:100,174,955...100,182,713
Ensembl chr10:100,156,238...100,182,647
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
decreases expression |
EXP |
bromobenzene results in decreased expression of IHH mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
|
|
G |
Ikzf4 |
IKAROS family zinc finger 4 |
increases expression |
EXP |
bromobenzene results in increased expression of IKZF4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:1,063,283...1,102,940
Ensembl chr 7:1,056,890...1,084,341
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IL13RA2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
|
|
G |
Il17rb |
interleukin 17 receptor B |
increases expression |
EXP |
bromobenzene results in increased expression of IL17RB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:5,180,431...5,194,125
Ensembl chr16:5,180,432...5,194,125
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
EXP |
bromobenzene results in increased expression of IL6R mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Inhba |
inhibin subunit beta A |
decreases expression |
EXP |
bromobenzene results in decreased expression of INHBA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Inka1 |
inka box actin regulator 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of INKA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:108,674,263...108,675,953
Ensembl chr 8:108,674,263...108,675,953
|
|
G |
Inpp4b |
inositol polyphosphate-4-phosphatase type II B |
increases expression |
EXP |
bromobenzene results in increased expression of INPP4B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634
|
|
G |
Insc |
INSC, spindle orientation adaptor protein |
increases expression |
EXP |
bromobenzene results in increased expression of INSC mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:168,993,032...169,100,438
Ensembl chr 1:168,993,032...169,100,433
|
|
G |
Insig1 |
insulin induced gene 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of INSIG1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Insig2 |
insulin induced gene 2 |
increases expression |
EXP |
bromobenzene results in increased expression of INSIG2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
|
|
G |
Ip6k2 |
inositol hexakisphosphate kinase 2 |
affects expression |
EXP |
bromobenzene affects the expression of IP6K2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:109,483,843...109,510,172
Ensembl chr 8:109,484,310...109,510,166
|
|
G |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
increases expression |
EXP |
bromobenzene results in increased expression of IQGAP3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956
|
|
G |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of IRF2BP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
|
|
G |
Irs2 |
insulin receptor substrate 2 |
increases expression |
EXP |
bromobenzene results in increased expression of IRS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Irx1 |
iroquois homeobox 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of IRX1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:31,294,615...31,300,444
Ensembl chr 1:31,294,615...31,300,444
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of ITIH4 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
|
|
G |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of JAKMIP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:73,646,299...73,766,830
Ensembl chr14:73,632,428...73,713,993
|
|
G |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of JAKMIP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:35,532,552...35,747,938
Ensembl chr18:35,532,552...35,747,775
|
|
G |
Kcnf1 |
potassium voltage-gated channel modifier subfamily F member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of KCNF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:39,962,301...39,964,979
Ensembl chr 6:39,962,307...39,964,979
|
|
G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
decreases expression |
EXP |
bromobenzene results in decreased expression of KCNJ15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
|
|
G |
Kcnk1 |
potassium two pore domain channel subfamily K member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of KCNK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:53,959,411...53,997,726
Ensembl chr19:53,959,657...53,997,724
|
|
G |
Kcnk2 |
potassium two pore domain channel subfamily K member 2 |
increases expression |
EXP |
bromobenzene results in increased expression of KCNK2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
|
|
G |
Kcnt1 |
potassium sodium-activated channel subfamily T member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of KCNT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:8,682,964...8,736,615
Ensembl chr 3:8,682,113...8,736,667
|
|
G |
Kctd15 |
potassium channel tetramerization domain containing 15 |
increases expression |
EXP |
bromobenzene results in increased expression of KCTD15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:87,258,658...87,271,979
Ensembl chr 1:87,258,658...87,273,497
|
|
G |
Kif23 |
kinesin family member 23 |
increases expression |
EXP |
bromobenzene results in increased expression of KIF23 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Kif6 |
kinesin family member 6 |
increases expression |
EXP |
bromobenzene results in increased expression of KIF6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:11,076,203...11,373,205
Ensembl chr 9:11,072,824...11,373,006
|
|
G |
Kir3dl1 |
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 |
increases expression |
EXP |
bromobenzene results in increased expression of KIR3DL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:69,715,529...69,754,050
Ensembl chr 1:69,715,535...69,754,050
|
|
G |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of KIRREL3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:32,865,779...33,407,555
Ensembl chr 8:32,862,776...33,405,676
|
|
G |
Klc3 |
kinesin light chain 3 |
affects binding |
EXP |
bromobenzene metabolite binds to KLC3 protein |
CTD |
PMID:17305373 |
|
NCBI chr 1:79,045,842...79,055,809
Ensembl chr 1:79,045,844...79,055,416
|
|
G |
Klf10 |
KLF transcription factor 10 |
increases expression |
EXP |
bromobenzene results in increased expression of KLF10 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Klf12 |
KLF transcription factor 12 |
decreases expression |
EXP |
bromobenzene results in decreased expression of KLF12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
|
|
G |
Klf15 |
KLF transcription factor 15 |
increases expression |
EXP |
bromobenzene results in increased expression of KLF15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Klf9 |
KLF transcription factor 9 |
increases expression |
EXP |
bromobenzene results in increased expression of KLF9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
|
|
G |
Krt23 |
keratin 23 |
increases expression |
EXP |
bromobenzene results in increased expression of KRT23 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983
|
|
G |
Lad1 |
ladinin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of LAD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of LAP3 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr14:65,608,375...65,627,359
Ensembl chr14:65,608,376...65,627,359
|
|
G |
Ldhb |
lactate dehydrogenase B |
decreases expression |
EXP |
bromobenzene results in decreased expression of LDHB mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
EXP |
bromobenzene results in decreased expression of LDLR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lgi2 |
leucine-rich repeat LGI family, member 2 |
increases expression |
EXP |
bromobenzene results in increased expression of LGI2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:58,415,965...58,443,450
Ensembl chr14:58,415,965...58,443,407
|
|
G |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
decreases expression |
EXP |
bromobenzene results in decreased expression of LGR5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
|
|
G |
Lgsn |
lengsin, lens protein with glutamine synthetase domain |
decreases expression |
EXP |
bromobenzene results in decreased expression of LGSN mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:33,416,362...33,447,919
Ensembl chr 9:33,420,484...33,447,907
|
|
G |
Lonp1 |
lon peptidase 1, mitochondrial |
increases expression |
EXP |
bromobenzene results in increased expression of LONP1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
|
|
G |
Lonrf3 |
LON peptidase N-terminal domain and ring finger 3 |
increases expression |
EXP |
bromobenzene results in increased expression of LONRF3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:115,565,214...115,603,886
Ensembl chr X:115,565,267...115,598,809
|
|
G |
Lox |
lysyl oxidase |
increases expression |
EXP |
bromobenzene results in increased expression of LOX mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lpar3 |
lysophosphatidic acid receptor 3 |
increases expression |
EXP |
bromobenzene results in increased expression of LPAR3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357
|
|
G |
Lpin1 |
lipin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of LPIN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lrrc4 |
leucine rich repeat containing 4 |
increases expression |
EXP |
bromobenzene results in increased expression of LRRC4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:57,433,518...57,437,114
Ensembl chr 4:57,433,428...57,437,911
|
|
G |
Lrrc58 |
leucine rich repeat containing 58 |
increases expression |
EXP |
bromobenzene results in increased expression of LRRC58 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:62,850,507...62,862,829
Ensembl chr11:62,847,562...62,862,829
|
|
G |
Lst1 |
leukocyte specific transcript 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of LST1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:3,634,680...3,639,731
Ensembl chr20:3,634,749...3,637,997
|
|
G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of LTBP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
|
|
G |
Lypd1 |
Ly6/Plaur domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of LYPD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
|
|
G |
Lypd3 |
Ly6/Plaur domain containing 3 |
affects expression |
EXP |
bromobenzene affects the expression of LYPD3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:80,226,449...80,230,901
Ensembl chr 1:80,226,449...80,230,901
|
|
G |
Mab21l3 |
mab-21 like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of MAB21L3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:189,248,895...189,271,652
Ensembl chr 2:189,248,895...189,271,652
|
|
G |
Mafb |
MAF bZIP transcription factor B |
increases expression |
EXP |
bromobenzene results in increased expression of MAFB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
EXP |
bromobenzene results in increased expression of MAFF mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MAGI3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:191,514,726...191,717,048
Ensembl chr 2:191,518,506...191,716,735
|
|
G |
Mal |
mal, T-cell differentiation protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of MAL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
increases expression |
EXP |
bromobenzene results in increased expression of MAP3K5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
increases expression |
EXP |
bromobenzene results in increased expression of MAP3K6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212
|
|
G |
Map3k9 |
mitogen-activated protein kinase kinase kinase 9 |
increases expression |
EXP |
bromobenzene results in increased expression of MAP3K9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:101,423,754...101,488,822
Ensembl chr 6:101,430,292...101,488,822
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases phosphorylation |
ISO |
bromobenzene analog results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:19427879 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of MAPKAPK3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Marchf1 |
membrane associated ring-CH-type finger 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MARCHF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:23,255,551...24,114,290
Ensembl chr16:23,258,799...24,114,277
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
increases expression |
EXP |
bromobenzene results in increased expression of MAT1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
|
|
G |
Mb |
myoglobin |
decreases expression |
EXP |
bromobenzene results in decreased expression of MB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
|
|
G |
Mcf2 |
MCF.2 cell line derived transforming sequence |
increases expression |
EXP |
bromobenzene results in increased expression of MCF2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:138,414,077...138,514,828
Ensembl chr X:138,409,256...138,514,446
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
increases expression |
EXP |
bromobenzene results in increased expression of MCM10 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MCM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MCM6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
|
|
G |
Mcoln2 |
mucolipin TRP cation channel 2 |
increases expression |
EXP |
bromobenzene results in increased expression of MCOLN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:235,053,816...235,102,703
Ensembl chr 2:235,053,816...235,102,702
|
|
G |
Mcub |
mitochondrial calcium uniporter dominant negative subunit beta |
increases expression |
EXP |
bromobenzene results in increased expression of MCUB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:218,479,301...218,549,594
Ensembl chr 2:218,479,301...218,549,593
|
|
G |
Mdh1b |
malate dehydrogenase 1B |
decreases expression |
EXP |
bromobenzene results in decreased expression of MDH1B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:65,120,370...65,168,008
Ensembl chr 9:65,119,029...65,167,933
|
|
G |
Meiob |
meiosis specific with OB-fold |
decreases expression |
EXP |
bromobenzene results in decreased expression of MEIOB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:13,833,170...13,865,684
Ensembl chr10:13,833,750...13,865,046
|
|
G |
Metap2 |
methionyl aminopeptidase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of METAP2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:28,412,429...28,440,458
Ensembl chr 7:28,411,608...28,440,434
|
|
G |
Mex3b |
mex-3 RNA binding family member B |
increases expression |
EXP |
bromobenzene results in increased expression of MEX3B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:136,855,130...136,859,365
Ensembl chr 1:136,855,130...136,859,354
|
|
G |
Mfsd2a |
MFSD2 lysolipid transporter A, lysophospholipid |
increases expression |
EXP |
bromobenzene results in increased expression of MFSD2A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
|
|
G |
Mgat4b |
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B |
decreases expression |
EXP |
bromobenzene results in decreased expression of MGAT4B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:34,548,918...34,559,229
Ensembl chr10:34,549,433...34,559,229
|
|
G |
Mid1ip1 |
MID1 interacting protein 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MID1IP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:12,060,993...12,063,318
Ensembl chr X:12,060,883...12,065,774
|
|
G |
Mif |
macrophage migration inhibitory factor |
affects binding |
EXP |
bromobenzene metabolite binds to MIF protein |
CTD |
PMID:17305373 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mipol1 |
mirror-image polydactyly 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MIPOL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:74,755,293...75,090,403
Ensembl chr 6:74,755,395...75,086,811
|
|
G |
Mknk2 |
MAPK interacting serine/threonine kinase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MKNK2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
|
|
G |
Mmd2 |
monocyte to macrophage differentiation-associated 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MMD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773
|
|
G |
Mocos |
molybdenum cofactor sulfurase |
increases expression |
EXP |
bromobenzene results in increased expression of MOCOS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:15,931,659...15,977,415
Ensembl chr18:15,931,654...15,977,187
|
|
G |
Mprip |
myosin phosphatase Rho interacting protein |
increases expression |
EXP |
bromobenzene results in increased expression of MPRIP mRNA |
CTD |
PMID:15056800 |
|
NCBI chr10:44,453,949...44,573,843
Ensembl chr10:44,453,929...44,569,118
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MRC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mroh9 |
maestro heat-like repeat family member 9 |
increases expression |
EXP |
bromobenzene results in increased expression of MROH9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:75,387,800...75,443,118
Ensembl chr13:75,387,746...75,443,092
|
|
G |
Ms4a1 |
membrane spanning 4-domains A1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MS4A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
|
|
G |
Ms4a6bl1 |
membrane-spanning 4-domains, subfamily A, member 6B-like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MS4A6BL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:208,243,561...208,255,400
Ensembl chr 1:208,243,559...208,257,340
|
|
G |
Msantd1 |
Myb/SANT DNA binding domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MSANTD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:75,832,368...75,845,687
Ensembl chr14:75,835,380...75,844,183
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MSMO1 mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Mst1r |
macrophage stimulating 1 receptor |
decreases expression |
EXP |
bromobenzene results in decreased expression of MST1R mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:108,596,100...108,611,441
Ensembl chr 8:108,597,299...108,612,455
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
EXP |
bromobenzene results in increased expression of MT2A mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt4 |
metallothionein 4 |
increases expression |
EXP |
bromobenzene results in increased expression of MT4 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr19:10,863,813...10,865,909
Ensembl chr19:10,863,813...10,865,909
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
EXP |
bromobenzene results in increased expression of MTHFD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
decreases expression |
EXP |
bromobenzene results in decreased expression of MTHFR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Mtss1 |
MTSS I-BAR domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MTSS1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
|
|
G |
Muc13 |
mucin 13, cell surface associated |
decreases expression |
EXP |
bromobenzene results in decreased expression of MUC13 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:66,957,208...66,980,264
Ensembl chr11:66,960,595...66,984,727
|
|
G |
Mug1 |
murinoglobulin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MUG1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:155,076,270...155,130,051
Ensembl chr 4:155,076,312...155,130,051
|
|
G |
Mug2 |
murinoglobulin 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PZP mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:155,164,061...155,236,894
Ensembl chr 4:155,164,011...155,236,475
|
|
G |
Mvd |
mevalonate diphosphate decarboxylase |
decreases expression |
EXP |
bromobenzene results in decreased expression of MVD mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:50,496,366...50,506,429
Ensembl chr19:50,496,367...50,507,971
|
|
G |
Mvk |
mevalonate kinase |
decreases expression |
EXP |
bromobenzene results in decreased expression of MVK mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Mx1 |
MX dynamin like GTPase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MX1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of MYBL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
EXP |
bromobenzene results in increased expression of MYC mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh7b |
myosin heavy chain 7B |
increases expression |
EXP |
bromobenzene results in increased expression of MYH7B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:144,076,911...144,122,714
Ensembl chr 3:144,098,190...144,122,084
|
|
G |
Mylk3 |
myosin light chain kinase 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of MYLK3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:21,685,085...21,743,587
Ensembl chr19:21,691,929...21,742,954
|
|
G |
Myo9b |
myosin IXb |
decreases expression |
EXP |
bromobenzene results in decreased expression of MYO9B mRNA |
CTD |
PMID:15056800 PMID:32479839 |
|
NCBI chr16:17,945,379...18,030,114
Ensembl chr16:17,945,448...18,030,126
|
|
G |
Myom2 |
myomesin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of MYOM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:74,520,148...74,592,658
Ensembl chr16:74,520,157...74,592,772
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
increases expression |
EXP |
bromobenzene results in increased expression of NAMPT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nat8f5 |
N-acetyltransferase 8 (GCN5-related) family member 5 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NAT8F5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:118,260,323...118,285,038
Ensembl chr 4:118,260,252...118,285,704
|
|
G |
Ncald |
neurocalcin delta |
increases expression |
EXP |
bromobenzene results in increased expression of NCALD mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:68,534,421...68,964,496
|
|
G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of NCEH1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
|
|
G |
Ndst1 |
N-deacetylase and N-sulfotransferase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NDST1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:54,136,887...54,199,545
Ensembl chr18:54,140,779...54,178,191
|
|
G |
Neil2 |
nei-like DNA glycosylase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NEIL2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:37,444,676...37,454,863
Ensembl chr15:37,445,381...37,454,863
|
|
G |
Nes |
nestin |
increases expression |
EXP |
bromobenzene results in increased expression of NES mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NFE2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases localization increases expression |
ISO |
bromobenzene results in increased localization of NFE2L2 protein bromobenzene analog results in increased expression of NFE2L2 protein |
CTD |
PMID:18078705 PMID:19427879 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nherf1 |
NHERF family PDZ scaffold protein 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NHERF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:100,403,189...100,420,290
Ensembl chr10:100,403,069...100,420,598
|
|
G |
Nim1k |
NIM1 serine/threonine protein kinase |
increases expression |
EXP |
bromobenzene results in increased expression of NIM1K mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:51,670,764...51,714,782
Ensembl chr 2:51,670,772...51,714,762
|
|
G |
Nkx1-2 |
NK1 homeobox 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NKX1-2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:187,386,370...187,391,252
Ensembl chr 1:187,388,711...187,391,149
|
|
G |
Nmrk2 |
nicotinamide riboside kinase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NMRK2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:8,514,855...8,517,916
Ensembl chr 7:8,514,927...8,517,922
|
|
G |
Noct |
nocturnin |
increases expression |
EXP |
bromobenzene results in increased expression of NOCT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
|
|
G |
Nol8 |
nucleolar protein 8 |
increases expression |
EXP |
bromobenzene results in increased expression of NOL8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848
|
|
G |
Nox4 |
NADPH oxidase 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NOX4 mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NPAS2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
|
|
G |
Npm1 |
nucleophosmin 1 |
increases expression |
EXP |
bromobenzene results in increased expression of NPM1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NPR3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
|
|
G |
Npsr1 |
neuropeptide S receptor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NPSR1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:22,606,946...22,831,558
Ensembl chr 8:22,606,946...22,831,558
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
affects response to substance increases expression |
ISO EXP |
NQO1 protein affects the susceptibility to bromobenzene bromobenzene results in increased expression of NQO1 mRNA |
CTD |
PMID:10092053 PMID:15976192 PMID:17538237 PMID:32479839 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nrbf2 |
nuclear receptor binding factor 2 |
increases expression |
EXP |
bromobenzene results in increased expression of NRBF2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:21,308,555...21,326,881
Ensembl chr20:21,308,576...21,326,818
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of NREP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of NTRK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Nudt4 |
nudix hydrolase 4 |
increases expression |
EXP |
bromobenzene results in increased expression of NUDT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:30,188,100...30,204,615
Ensembl chr 7:30,188,100...30,204,615
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
decreases expression |
EXP |
bromobenzene results in decreased expression of NUPR1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
|
|
G |
Nxph3 |
neurexophilin 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of NXPH3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:80,456,283...80,459,949
Ensembl chr10:80,455,429...80,462,415
|
|
G |
Odf2l |
outer dense fiber of sperm tails 2-like |
increases expression |
EXP |
bromobenzene results in increased expression of ODF2L mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:234,036,049...234,072,751
Ensembl chr 2:234,033,652...234,072,747
|
|
G |
Olr35 |
olfactory receptor 35 |
increases expression |
EXP |
bromobenzene results in increased expression of OLR35 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:153,994,678...154,043,281
Ensembl chr 1:154,041,306...154,043,257
|
|
G |
Omd |
osteomodulin |
increases expression |
EXP |
bromobenzene results in increased expression of OMD mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:15,060,217...15,068,441
Ensembl chr17:15,060,217...15,068,441
|
|
G |
Orc1 |
origin recognition complex, subunit 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ORC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:123,324,273...123,348,375
Ensembl chr 5:123,324,315...123,348,375
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ORM1 mRNA |
CTD |
PMID:16036859 |
|
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
|
|
G |
Osbp2 |
oxysterol binding protein 2 |
increases expression |
EXP |
bromobenzene results in increased expression of OSBP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:78,585,088...78,746,785
Ensembl chr14:78,585,089...78,746,786
|
|
G |
Osbpl8 |
oxysterol binding protein-like 8 |
decreases expression |
EXP |
bromobenzene results in decreased expression of OSBPL8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
increases expression |
EXP |
bromobenzene results in increased expression of OSGIN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Otud6b |
OTU deubiquitinase 6B |
increases expression |
EXP |
bromobenzene results in increased expression of OTUD6B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:28,181,992...28,214,486
Ensembl chr 5:28,023,594...28,214,334
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of OXCT1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 2:53,236,370...53,384,715
Ensembl chr 2:53,236,368...53,384,714
|
|
G |
P2ry12 |
purinergic receptor P2Y12 |
increases expression |
EXP |
bromobenzene results in increased expression of P2RY12 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:143,481,468...143,523,340
Ensembl chr 2:143,481,430...143,523,361
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
affects binding |
EXP |
bromobenzene metabolite binds to P4HB protein |
CTD |
PMID:12018992 |
|
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
|
|
G |
Padi1 |
peptidyl arginine deiminase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PADI1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:153,119,566...153,152,034
Ensembl chr 5:153,119,566...153,152,034
|
|
G |
Park7 |
Parkinsonism associated deglycase |
affects binding |
EXP |
bromobenzene metabolite binds to PARK7 protein |
CTD |
PMID:17305373 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PARP14 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Pax3 |
paired box 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PAX3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:79,567,455...79,664,042
Ensembl chr 9:79,568,634...79,664,042
|
|
G |
Pax8 |
paired box 8 |
increases expression |
EXP |
bromobenzene results in increased expression of PAX8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
|
|
G |
Pcdh8 |
protocadherin 8 |
increases expression |
EXP |
bromobenzene results in increased expression of PCDH8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:55,198,470...55,203,039
Ensembl chr15:55,198,459...55,205,872
|
|
G |
Pcdhb3 |
protocadherin beta 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PCDHB3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:29,011,667...29,014,221
Ensembl chr18:29,011,816...29,015,188
|
|
G |
Pcp4 |
Purkinje cell protein 4 |
increases expression |
EXP |
bromobenzene results in increased expression of PCP4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PCSK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
|
|
G |
Pcsk9 |
proprotein convertase subtilisin/kexin type 9 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PCSK9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
|
|
G |
Pcyt1a |
phosphate cytidylyltransferase 1A, choline |
increases expression |
EXP |
bromobenzene results in increased expression of PCYT1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:68,313,860...68,357,828
Ensembl chr11:68,313,882...68,357,357
|
|
G |
Pde6c |
phosphodiesterase 6C |
decreases expression |
EXP |
bromobenzene results in decreased expression of PDE6C mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:235,909,583...235,965,435
Ensembl chr 1:235,909,775...235,965,315
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
increases expression |
EXP |
bromobenzene results in increased expression of PDGFRB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
affects binding |
EXP |
bromobenzene metabolite binds to PDIA3 protein |
CTD |
PMID:12018992 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pdia5 |
protein disulfide isomerase family A, member 5 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PDIA5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
|
|
G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
affects binding |
EXP |
bromobenzene metabolite binds to PDIA6 protein |
CTD |
PMID:12018992 |
|
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
increases expression |
EXP |
bromobenzene results in increased expression of PDK4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
affects binding |
EXP |
bromobenzene metabolite binds to PEBP1 protein |
CTD |
PMID:17305373 |
|
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
|
|
G |
Per1 |
period circadian regulator 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PER1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Per2 |
period circadian regulator 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PER2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
increases expression |
EXP |
bromobenzene results in increased expression of PEX11A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pfkfb1 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PFKFB1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:19,508,522...19,562,165
Ensembl chr X:19,508,546...19,562,182
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to PGK1 protein |
CTD |
PMID:17305373 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PHLDA1 mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
|
|
G |
Pigu |
phosphatidylinositol glycan anchor biosynthesis, class U |
increases expression |
EXP |
bromobenzene results in increased expression of PIGU mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:143,784,831...143,881,268
Ensembl chr 3:143,784,832...143,880,807
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PIK3R1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Pim3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases expression |
EXP |
bromobenzene results in increased expression of PIM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
|
|
G |
Pip4p2 |
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2 |
increases expression |
EXP |
bromobenzene results in increased expression of PIP4P2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:28,259,821...28,307,225
Ensembl chr 5:28,259,760...28,307,225
|
|
G |
Pir |
pirin |
increases expression |
EXP |
bromobenzene results in increased expression of PIR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
EXP |
bromobenzene results in decreased expression of PKLR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Plekhm3 |
pleckstrin homology domain containing M3 |
increases expression |
EXP |
bromobenzene results in increased expression of PLEKHM3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:66,166,233...66,325,332
Ensembl chr 9:66,166,321...66,325,294
|
|
G |
Plin2 |
perilipin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of PLIN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plin5 |
perilipin 5 |
increases expression |
EXP |
bromobenzene results in increased expression of PLIN5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:939,745...946,188
Ensembl chr 9:939,747...946,120
|
|
G |
Plk3 |
polo-like kinase 3 |
increases expression |
EXP |
bromobenzene results in increased expression of PLK3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Plppr1 |
phospholipid phosphatase related 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PLPPR1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:63,437,457...63,725,286
Ensembl chr 5:63,437,816...63,763,835
|
|
G |
Plppr3 |
phospholipid phosphatase related 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PLPPR3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:9,831,162...9,842,434
Ensembl chr 7:9,831,162...9,845,296
|
|
G |
Pls1 |
plastin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PLS1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:96,316,703...96,426,592
Ensembl chr 8:96,317,849...96,385,195
|
|
G |
Plxna2 |
plexin A2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PLXNA2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PNPLA3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Polg2 |
DNA polymerase gamma 2, accessory subunit |
increases expression |
EXP |
bromobenzene results in increased expression of POLG2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:91,712,586...91,723,008
Ensembl chr10:91,712,586...91,723,008
|
|
G |
Polq |
DNA polymerase theta |
increases expression |
EXP |
bromobenzene results in increased expression of POLQ mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:63,673,796...63,775,905
Ensembl chr11:63,673,816...63,775,878
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases expression |
EXP |
bromobenzene results in increased expression of POR mRNA |
CTD |
PMID:12628495 PMID:32479839 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
increases expression |
EXP |
bromobenzene results in increased expression of PPARGC1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
increases expression |
EXP |
bromobenzene results in increased expression of PPAT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:31,215,741...31,250,144
Ensembl chr14:31,216,165...31,250,144
|
|
G |
Ppcs |
phosphopantothenoylcysteine synthetase |
increases expression |
EXP |
bromobenzene results in increased expression of PPCS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:133,023,077...133,026,899
Ensembl chr 5:133,023,121...133,026,933
|
|
G |
Ppm1k |
protein phosphatase, Mg2+/Mn2+ dependent, 1K |
increases expression |
EXP |
bromobenzene results in increased expression of PPM1K mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:87,612,198...87,638,993
Ensembl chr 4:87,612,204...87,636,152
|
|
G |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
increases expression |
EXP |
bromobenzene results in increased expression of PPP1R3G mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:28,874,956...28,878,288
Ensembl chr17:28,876,482...28,877,525
|
|
G |
Ppp2r1b |
protein phosphatase 2 scaffold subunit A beta |
increases expression |
EXP |
bromobenzene results in increased expression of PPP2R1B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
|
|
G |
Pptc7 |
protein phosphatase targeting COQ7 |
increases expression |
EXP |
bromobenzene results in increased expression of PPTC7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:34,249,963...34,288,339
Ensembl chr12:34,249,977...34,288,339
|
|
G |
Prdx6 |
peroxiredoxin 6 |
affects binding |
EXP |
bromobenzene metabolite binds to PRDX6 protein |
CTD |
PMID:17305373 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Prickle1 |
prickle planar cell polarity protein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PRICKLE1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:124,639,142...124,735,027
Ensembl chr 7:124,639,142...124,658,113
|
|
G |
Prima1 |
proline rich membrane anchor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PRIMA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:122,338,365...122,390,955
Ensembl chr 6:122,338,370...122,389,921
|
|
G |
Prkag3 |
protein kinase AMP-activated non-catalytic subunit gamma 3 |
increases expression |
EXP |
bromobenzene results in increased expression of PRKAG3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:76,295,715...76,304,959
Ensembl chr 9:76,295,715...76,304,959
|
|
G |
Prmt7 |
protein arginine methyltransferase 7 |
increases expression |
EXP |
bromobenzene results in increased expression of PRMT7 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:34,110,724...34,161,531
Ensembl chr19:34,110,747...34,162,577
|
|
G |
Prok1 |
prokineticin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PROK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:194,850,539...194,859,343
Ensembl chr 2:194,853,991...194,859,250
|
|
G |
Prpf3 |
pre-mRNA processing factor 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PRPF3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:183,379,041...183,403,526
Ensembl chr 2:183,378,718...183,403,489
|
|
G |
Prr30 |
proline rich 30 |
increases expression |
EXP |
bromobenzene results in increased expression of PRR30 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:25,415,069...25,417,582
Ensembl chr 6:25,414,868...25,417,585
|
|
G |
Prrg4 |
proline rich and Gla domain 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PRRG4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
|
|
G |
Prtfdc1 |
phosphoribosyl transferase domain containing 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of PRTFDC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr17:83,549,608...83,654,517
Ensembl chr17:83,548,803...83,655,179
|
|
G |
Psma1 |
proteasome 20S subunit alpha 1 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMA1 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:168,442,421...168,453,440
Ensembl chr 1:168,440,936...168,453,472
|
|
G |
Psma3 |
proteasome 20S subunit alpha 3 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMA3 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 6:89,483,741...89,503,775
Ensembl chr 6:89,483,727...89,504,965
|
|
G |
Psmb3 |
proteasome 20S subunit beta 3 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMB3 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMB5 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
|
|
G |
Psmc3 |
proteasome 26S subunit, ATPase 3 |
affects binding |
EXP |
bromobenzene metabolite binds to PSMC3 protein |
CTD |
PMID:17305373 |
|
NCBI chr 3:77,031,825...77,037,207
Ensembl chr 3:77,031,825...77,043,358
|
|
G |
Psmc4 |
proteasome 26S subunit, ATPase 4 |
affects binding |
EXP |
bromobenzene metabolite binds to PSMC4 protein |
CTD |
PMID:17305373 |
|
NCBI chr 1:83,349,127...83,357,497
Ensembl chr 1:83,348,592...83,357,494
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMC5 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
|
|
G |
Psmd5 |
proteasome 26S subunit, non-ATPase 5 |
increases expression |
EXP |
bromobenzene results in increased expression of PSMD5 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 3:18,133,715...18,151,000
Ensembl chr 3:18,133,717...18,151,029
|
|
G |
Psme1 |
proteasome activator subunit 1 |
affects binding |
EXP |
bromobenzene metabolite binds to PSME1 protein |
CTD |
PMID:17305373 |
|
NCBI chr15:29,069,012...29,071,888
Ensembl chr15:29,068,729...29,071,890
|
|
G |
Ptgds |
prostaglandin D2 synthase |
increases expression |
EXP |
bromobenzene results in increased expression of PTGDS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[bromobenzene co-treated with EGLN1 mutant form] results in increased expression of PTGS2 mRNA |
CTD |
PMID:24190904 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptma |
prothymosin alpha |
increases expression |
EXP |
bromobenzene results in increased expression of PTMA mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
|
|
G |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
increases expression |
EXP |
bromobenzene results in increased expression of PTPN14 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:101,268,258...101,420,508
Ensembl chr13:101,268,416...101,414,088
|
|
G |
Ptprcap |
protein tyrosine phosphatase, receptor type, C-associated protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of PTPRCAP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:201,449,133...201,451,293
Ensembl chr 1:201,449,113...201,451,288
|
|
G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
increases expression |
EXP |
bromobenzene results in increased expression of PTPRG mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:12,871,706...13,552,186
Ensembl chr15:12,871,721...13,554,094
|
|
G |
Ptpru |
protein tyrosine phosphatase, receptor type, U |
increases expression |
EXP |
bromobenzene results in increased expression of PTPRU mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:143,950,542...144,024,791
Ensembl chr 5:143,950,965...144,024,768
|
|
G |
Pvr |
PVR cell adhesion molecule |
increases expression |
EXP |
bromobenzene results in increased expression of PVR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
|
|
G |
Pygm |
glycogen phosphorylase, muscle associated |
decreases expression |
EXP |
bromobenzene results in decreased expression of PYGM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368
|
|
G |
Qrfpr |
pyroglutamylated RFamide peptide receptor |
increases expression |
EXP |
bromobenzene results in increased expression of QRFPR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:119,053,083...119,096,864
Ensembl chr 2:119,053,511...119,096,792
|
|
G |
Rab23 |
RAB23, member RAS oncogene family |
increases expression |
EXP |
bromobenzene results in increased expression of RAB23 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:35,943,522...35,967,367
Ensembl chr 9:35,944,085...35,966,927
|
|
G |
Rab30 |
RAB30, member RAS oncogene family |
increases expression |
EXP |
bromobenzene results in increased expression of RAB30 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181
|
|
G |
Rab9b |
RAB9B, member RAS oncogene family |
decreases expression |
EXP |
bromobenzene results in decreased expression of RAB9B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:100,220,897...100,231,591
Ensembl chr X:100,220,894...100,231,701
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression |
EXP |
bromobenzene results in decreased expression of RAD51 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rad54l2 |
RAD54 like 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RAD54L2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:107,324,945...107,427,033
Ensembl chr 8:107,327,420...107,427,106
|
|
G |
Ran |
RAN, member RAS oncogene family |
increases expression |
EXP |
bromobenzene results in increased expression of RAN mRNA |
CTD |
PMID:12628495 |
|
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
increases expression |
EXP |
bromobenzene results in increased expression of RASD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
|
|
G |
Rasl10a |
RAS-like, family 10, member A |
decreases expression |
EXP |
bromobenzene results in decreased expression of RASL10A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:79,955,093...79,956,471
Ensembl chr14:79,954,398...79,956,468
|
|
G |
Rec8 |
REC8 meiotic recombination protein |
increases expression |
EXP |
bromobenzene results in increased expression of REC8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:29,109,862...29,117,327
Ensembl chr15:29,109,863...29,117,326
|
|
G |
Reg4 |
regenerating family member 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of REG4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:185,818,946...185,833,252
Ensembl chr 2:185,821,210...185,833,353
|
|
G |
RGD1562699 |
RGD1562699 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RGD1562699 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:57,826,815...57,831,464
Ensembl chr18:57,827,117...57,827,989
|
|
G |
Rgma |
repulsive guidance molecule BMP co-receptor a |
increases expression |
EXP |
bromobenzene results in increased expression of RGMA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:127,128,934...127,172,918
Ensembl chr 1:127,128,934...127,172,918
|
|
G |
Rgn |
regucalcin |
affects binding |
EXP |
bromobenzene metabolite binds to RGN protein |
CTD |
PMID:17305373 |
|
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
increases expression |
EXP |
bromobenzene results in increased expression of RGS1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
|
|
G |
Rgs20 |
regulator of G-protein signaling 20 |
increases expression |
EXP |
bromobenzene results in increased expression of RGS20 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:14,484,436...14,614,317
Ensembl chr 5:14,534,775...14,614,084
|
|
G |
Rgs3 |
regulator of G-protein signaling 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RGS3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
|
|
G |
Rgs9bp |
regulator of G protein signaling 9 binding protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of RGS9BP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:88,249,438...88,250,151
Ensembl chr 1:88,249,438...88,250,151
|
|
G |
Rhbdd2 |
rhomboid domain containing 2 |
increases expression |
EXP |
bromobenzene results in increased expression of RHBDD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:21,043,605...21,054,305
Ensembl chr12:21,043,608...21,054,289
|
|
G |
Rida |
reactive intermediate imine deaminase A homolog |
affects binding |
EXP |
bromobenzene metabolite binds to RIDA protein |
CTD |
PMID:17305373 |
|
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
|
|
G |
Rlim |
ring finger protein, LIM domain interacting |
increases expression |
EXP |
bromobenzene results in increased expression of RLIM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:68,983,259...69,004,368
Ensembl chr X:68,988,375...69,004,271
|
|
G |
Rnase11 |
ribonuclease A family member 11 |
affects expression |
EXP |
bromobenzene affects the expression of RNASE11 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:24,268,206...24,270,192
Ensembl chr15:24,268,207...24,270,192
|
|
G |
Rnf151 |
ring finger protein 151 |
increases expression |
EXP |
bromobenzene results in increased expression of RNF151 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:13,742,682...13,747,192
Ensembl chr10:13,742,682...13,745,000
|
|
G |
Ropn1 |
rhophilin associated tail protein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ROPN1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:66,097,854...66,127,148
Ensembl chr11:66,097,856...66,127,148
|
|
G |
Rpl15 |
ribosomal protein L15 |
increases expression |
EXP |
bromobenzene results in increased expression of RPL15 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr15:7,503,883...7,507,166
Ensembl chr15:7,503,883...7,507,165
|
|
G |
Rpl22 |
ribosomal protein L22 |
increases expression |
EXP |
bromobenzene results in increased expression of RPL22 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr 5:162,835,241...162,843,394
Ensembl chr 5:162,833,740...162,843,368 Ensembl chr 7:162,833,740...162,843,368 Ensembl chr 4:162,833,740...162,843,368
|
|
G |
Rpl27a |
ribosomal protein L27A |
increases expression |
EXP |
bromobenzene results in increased expression of RPL27A mRNA |
CTD |
PMID:16036859 |
|
NCBI chr 1:163,539,732...163,542,771
|
|
G |
Rpl35 |
ribosomal protein L35 |
increases expression decreases expression |
EXP |
bromobenzene results in increased expression of RPL35 mRNA bromobenzene results in decreased expression of RPL35 mRNA |
CTD |
PMID:12628495 PMID:15056800 |
|
NCBI chr 3:22,753,255...22,756,217
Ensembl chr 3:22,753,253...22,756,243
|
|
G |
Rpl6 |
ribosomal protein L6 |
increases expression |
EXP |
bromobenzene results in increased expression of RPL6 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
|
|
G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator homolog |
increases expression |
EXP |
bromobenzene results in increased expression of RPRM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:38,539,581...38,540,998
Ensembl chr 3:38,539,581...38,540,998
|
|
G |
Rps11 |
ribosomal protein S11 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS11 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:95,605,690...95,607,798
Ensembl chr 1:95,605,692...95,607,874
|
|
G |
Rps2 |
ribosomal protein S2 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr10:13,747,316...13,749,165
Ensembl chr10:13,747,301...13,749,163
|
|
G |
Rps26 |
ribosomal protein S26 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS26 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 7:1,057,332...1,058,882
|
|
G |
Rps26l1 |
ribosomal protein S26 like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS26L1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:62,981,687...62,982,757
Ensembl chr 7:62,981,946...62,982,326
|
|
G |
Rps3a |
ribosomal protein S3a |
increases expression |
EXP |
bromobenzene results in increased expression of RPS3A mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:171,524,685...171,529,054
Ensembl chr 2:171,524,500...171,529,055
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS6KB1 mRNA |
CTD |
PMID:15056800 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Rps8 |
ribosomal protein S8 |
increases expression |
EXP |
bromobenzene results in increased expression of RPS8 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 5:130,630,362...130,632,932
Ensembl chr 5:130,629,716...130,633,268
|
|
G |
Rrp9 |
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein |
decreases expression |
EXP |
bromobenzene results in decreased expression of RRP9 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:107,116,411...107,126,123
Ensembl chr 8:107,117,471...107,126,123
|
|
G |
Rsrp1 |
arginine and serine rich protein 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RSRP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
|
|
G |
RT1-CE10 |
RT1 class I, locus CE10 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-CE10 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:3,377,284...3,380,301
|
|
G |
RT1-CE3 |
RT1 class I, locus CE3 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-CE3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:3,516,647...3,520,938
Ensembl chr20:2,623,953...2,692,081
|
|
G |
RT1-M2 |
RT1 class Ib, locus M2 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-M2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:978,918...981,510
Ensembl chr20:978,935...981,723
|
|
G |
RT1-M6-2 |
RT1 class I, locus M6, gene 2 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-M6-2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:1,583,267...1,587,099
Ensembl chr20:1,583,299...1,586,215
|
|
G |
RT1-N1 |
RT1 class Ib, locus N1 |
increases expression decreases expression |
EXP |
bromobenzene results in increased expression of RT1-N1 mRNA bromobenzene results in decreased expression of RT1-N1 mRNA |
CTD |
PMID:12628495 PMID:15056800 |
|
|
|
G |
RT1-S2 |
RT1 class Ib, locus S2 |
increases expression |
EXP |
bromobenzene results in increased expression of RT1-S2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:2,650,233...2,651,654
Ensembl chr20:2,649,964...2,652,027
|
|
G |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of RTN4RL2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:69,954,557...69,971,108
Ensembl chr 3:69,955,169...69,971,488
|
|
G |
Sacs |
sacsin molecular chaperone |
increases expression |
EXP |
bromobenzene results in increased expression of SACS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:35,285,783...35,370,335
Ensembl chr15:35,285,782...35,370,335
|
|
G |
Samd4a |
sterile alpha motif domain containing 4A |
increases expression |
EXP |
bromobenzene results in increased expression of SAMD4A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380
|
|
G |
Sapcd2 |
suppressor APC domain containing 2 |
increases expression |
EXP |
bromobenzene results in increased expression of SAPCD2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
|
|
G |
Sash1 |
SAM and SH3 domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SASH1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:3,119,915...3,418,536
Ensembl chr 1:3,121,332...3,439,870
|
|
G |
Saxo2 |
stabilizer of axonemal microtubules 2 |
increases expression |
EXP |
bromobenzene results in increased expression of SAXO2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:136,596,445...136,638,444
Ensembl chr 1:136,623,493...136,638,454
|
|
G |
Sbds |
Sbds, ribosome maturation factor |
decreases expression |
EXP |
bromobenzene results in decreased expression of SBDS mRNA |
CTD |
PMID:12628495 |
|
NCBI chr12:26,420,410...26,429,650
Ensembl chr12:26,420,414...26,429,649
|
|
G |
Sc5d |
sterol-C5-desaturase |
decreases expression |
EXP |
bromobenzene results in decreased expression of SC5D mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression increases expression |
EXP |
bromobenzene results in decreased expression of SCD1 mRNA bromobenzene results in increased expression of SCD mRNA |
CTD |
PMID:15976192 PMID:32479839 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scn4b |
sodium voltage-gated channel beta subunit 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SCN4B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:45,446,580...45,462,294
Ensembl chr 8:45,446,215...45,462,292
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
increases expression |
EXP |
bromobenzene results in increased expression of SCNN1A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
|
|
G |
Sdc4 |
syndecan 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SDC4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
|
|
G |
Sds |
serine dehydratase |
increases expression |
EXP |
bromobenzene results in increased expression of SDS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:36,083,226...36,090,540
Ensembl chr12:36,083,229...36,088,203
|
|
G |
Sebox |
SEBOX homeobox |
decreases expression |
EXP |
bromobenzene results in decreased expression of SEBOX mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:63,399,215...63,400,086
Ensembl chr10:63,399,165...63,400,606
|
|
G |
Selenbp1 |
selenium binding protein 1 |
affects binding |
EXP |
bromobenzene metabolite binds to SELENBP1 protein |
CTD |
PMID:17305373 |
|
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
|
|
G |
Selenop |
selenoprotein P |
decreases expression |
EXP |
bromobenzene results in decreased expression of SELENOP mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Sell |
selectin L |
decreases expression |
EXP |
bromobenzene results in decreased expression of SELL mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Sema6b |
semaphorin 6B |
increases expression |
EXP |
bromobenzene results in increased expression of SEMA6B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:950,939...967,905
Ensembl chr 9:950,939...961,521
|
|
G |
Sesn2 |
sestrin 2 |
increases expression |
EXP |
bromobenzene results in increased expression of SESN2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Setbp1 |
SET binding protein 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SETBP1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:72,190,542...72,551,272
Ensembl chr18:72,191,035...72,552,556
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SGK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SGK2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
|
|
G |
Sh2d4a |
SH2 domain containing 4A |
decreases expression |
EXP |
bromobenzene results in decreased expression of SH2D4A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:21,339,010...21,409,360
Ensembl chr16:21,340,015...21,409,260
|
|
G |
Sh3pxd2b |
SH3 and PX domains 2B |
increases expression |
EXP |
bromobenzene results in increased expression of SH3PXD2B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:16,918,611...17,027,499
Ensembl chr10:16,918,679...17,005,170
|
|
G |
Sidt1 |
SID1 transmembrane family, member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SIDT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:56,362,788...56,459,939
Ensembl chr11:56,363,512...56,459,050
|
|
G |
Siglec5 |
sialic acid binding Ig-like lectin 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SIGLEC5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:93,768,190...93,776,696
Ensembl chr 1:93,768,319...93,776,694
|
|
G |
Slamf6 |
SLAM family member 6 |
increases expression |
EXP |
bromobenzene results in increased expression of SLAMF6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:84,384,561...84,405,300
Ensembl chr13:84,383,742...84,405,300
|
|
G |
Slc10a2 |
solute carrier family 10 member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC10A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:84,386,528...84,409,475
Ensembl chr16:84,374,862...84,409,475
|
|
G |
Slc10a6 |
solute carrier family 10 member 6 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC10A6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:6,080,716...6,102,902
Ensembl chr14:6,080,717...6,103,037
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC11A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
|
|
G |
Slc13a2 |
solute carrier family 13 member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC13A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127
|
|
G |
Slc13a4 |
solute carrier family 13 member 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC13A4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
|
|
G |
Slc13a5 |
solute carrier family 13 member 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC13A5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:56,866,249...56,891,189
Ensembl chr10:56,866,249...56,890,945
|
|
G |
Slc15a4 |
solute carrier family 15 member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC15A4 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr12:29,048,634...29,082,480
Ensembl chr12:29,063,015...29,082,480
|
|
G |
Slc16a5 |
solute carrier family 16 member 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC16A5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:100,707,434...100,721,338
Ensembl chr10:100,707,434...100,721,338
|
|
G |
Slc17a9 |
solute carrier family 17 member 9 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC17A9 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:167,839,246...167,857,462
Ensembl chr 3:167,839,385...167,855,985
|
|
G |
Slc19a2 |
solute carrier family 19 member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC19A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172
|
|
G |
Slc1a3 |
solute carrier family 1 member 3 |
affects expression |
EXP |
bromobenzene affects the expression of SLC1A3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
|
|
G |
Slc1a4 |
solute carrier family 1 member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC1A4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC22A5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
|
|
G |
Slc25a15 |
solute carrier family 25 member 15 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A15 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:69,631,581...69,654,869
Ensembl chr16:69,634,414...69,653,010
|
|
G |
Slc25a25 |
solute carrier family 25 member 25 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A25 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:15,708,702...15,742,195
Ensembl chr 3:15,708,703...15,742,216
|
|
G |
Slc25a27 |
solute carrier family 25, member 27 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A27 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 9:17,306,898...17,333,942
Ensembl chr 9:17,307,023...17,332,731
|
|
G |
Slc25a29 |
solute carrier family 25 member 29 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A29 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:127,742,027...127,752,915
Ensembl chr 6:127,742,033...127,752,940
|
|
G |
Slc25a30 |
solute carrier family 25, member 30 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC25A30 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:51,076,998...51,099,613
Ensembl chr15:51,077,002...51,099,613
|
|
G |
Slc25a32 |
solute carrier family 25 member 32 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC25A32 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:70,142,958...70,160,726
Ensembl chr 7:70,142,964...70,160,770
|
|
G |
Slc29a4 |
solute carrier family 29 member 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC29A4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:11,853,540...11,884,660
Ensembl chr12:11,853,540...11,874,834
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC2A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc34a2 |
solute carrier family 34 member 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC34A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
|
|
G |
Slc35g1 |
solute carrier family 35, member G1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC35G1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:236,163,593...236,172,115
Ensembl chr 1:236,163,175...236,170,262
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC38A2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
|
|
G |
Slc43a1 |
solute carrier family 43 member 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC43A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:69,920,586...69,946,768
Ensembl chr 3:69,920,649...69,946,768
|
|
G |
Slc44a3 |
solute carrier family 44, member 3 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC44A3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:209,552,138...209,628,182
Ensembl chr 2:209,552,144...209,629,044
|
|
G |
Slc45a3 |
solute carrier family 45, member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC45A3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588
|
|
G |
Slc4a11 |
solute carrier family 4 member 11 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLC4A11 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:117,900,223...117,912,787
Ensembl chr 3:117,900,223...117,912,674
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC4A4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
|
|
G |
Slc4a5 |
solute carrier family 4 member 5 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC4A5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:115,710,101...115,810,330
Ensembl chr 4:115,725,592...115,810,323
|
|
G |
Slc51a |
solute carrier family 51 member A |
increases expression |
EXP |
bromobenzene results in increased expression of SLC51A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
|
|
G |
Slc5a8 |
solute carrier family 5 member 8 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC5A8 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:23,272,891...23,313,811
Ensembl chr 7:23,272,427...23,314,642
|
|
G |
Slc6a14 |
solute carrier family 6 member 14 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC6A14 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
|
|
G |
Slc6a6 |
solute carrier family 6 member 6 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC6A6 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:124,195,186...124,268,880
Ensembl chr 4:124,195,218...124,268,875
|
|
G |
Slc7a1 |
solute carrier family 7 member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC7A1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
EXP |
bromobenzene results in increased expression of SLC7A11 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SLCO1A4 mRNA |
CTD |
PMID:15976192 PMID:32479839 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLCO1C1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:174,466,621...174,513,290
Ensembl chr 4:174,466,631...174,513,289
|
|
G |
Slit1 |
slit guidance ligand 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLIT1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127
|
|
G |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SLITRK1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:85,723,252...85,727,290
Ensembl chr15:85,724,475...85,727,509
|
|
G |
Smox |
spermine oxidase |
increases expression |
EXP |
bromobenzene results in increased expression of SMOX mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
|
|
G |
Sntb1 |
syntrophin, beta 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SNTB1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:87,060,926...87,329,315
Ensembl chr 7:87,060,926...87,329,315
|
|
G |
Sod1 |
superoxide dismutase 1 |
affects binding |
EXP |
bromobenzene metabolite binds to SOD1 protein |
CTD |
PMID:17305373 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sord |
sorbitol dehydrogenase |
increases activity |
EXP |
bromobenzene results in increased activity of SORD protein |
CTD |
PMID:3012827 |
|
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
|
|
G |
Spdya |
speedy/RINGO cell cycle regulator family member A |
decreases expression |
EXP |
bromobenzene results in decreased expression of SPDYA mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:23,905,574...23,954,926
Ensembl chr 6:23,910,223...23,954,850
|
|
G |
Spib |
Spi-B transcription factor |
decreases expression |
EXP |
bromobenzene results in decreased expression of SPIB mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:95,018,939...95,024,804
Ensembl chr 1:95,018,947...95,024,780
|
|
G |
Spring1 |
SREBF pathway regulator in golgi 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SPRING1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:38,306,227...38,329,175
Ensembl chr12:38,297,837...38,329,138
|
|
G |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SPSB1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468
|
|
G |
Spsb4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
increases expression |
EXP |
bromobenzene results in increased expression of SPSB4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:97,536,519...97,609,757
Ensembl chr 8:97,536,520...97,609,787
|
|
G |
Sqle |
squalene epoxidase |
decreases expression |
EXP |
bromobenzene results in decreased expression of SQLE mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SREBF1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srp68 |
signal recognition particle 68 |
increases expression |
EXP |
bromobenzene results in increased expression of SRP68 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:101,481,213...101,508,035
Ensembl chr10:101,481,212...101,508,035
|
|
G |
Sstr3 |
somatostatin receptor 3 |
increases expression |
EXP |
bromobenzene results in increased expression of SSTR3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
|
|
G |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
increases expression |
EXP |
bromobenzene results in increased expression of ST8SIA1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:175,782,989...175,921,338
Ensembl chr 4:175,789,947...175,920,708
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of STAC3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
|
|
G |
Stard4 |
StAR-related lipid transfer domain containing 4 |
decreases expression |
EXP |
bromobenzene results in decreased expression of STARD4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
|
|
G |
Stc1 |
stanniocalcin 1 |
decreases expression |
EXP |
bromobenzene results in decreased expression of STC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
|
|
G |
Steap2 |
STEAP2 metalloreductase |
increases expression |
EXP |
bromobenzene results in increased expression of STEAP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:28,347,769...28,368,177
Ensembl chr 4:28,348,362...28,375,791
|
|
G |
Stoml3 |
stomatin like 3 |
increases expression |
EXP |
bromobenzene results in increased expression of STOML3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:137,572,691...137,582,402
Ensembl chr 2:137,572,691...137,590,681
|
|
G |
Stxbp5l |
syntaxin binding protein 5L |
increases expression |
EXP |
bromobenzene results in increased expression of STXBP5L mRNA |
CTD |
PMID:32479839 |
|
NCBI chr11:63,334,667...63,654,270
Ensembl chr11:63,334,667...63,657,014
|
|
G |
Sult1b1 |
sulfotransferase family 1B member 1 |
affects binding |
EXP |
bromobenzene metabolite binds to SULT1B1 protein |
CTD |
PMID:17305373 |
|
NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SULT1C1 mRNA |
CTD |
PMID:15976192 |
|
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
|
|
G |
Svop |
SV2 related protein |
increases expression |
EXP |
bromobenzene results in increased expression of SVOP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:42,530,991...42,589,381
Ensembl chr12:42,531,032...42,590,572
|
|
G |
Synj2 |
synaptojanin 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SYNJ2 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 1:46,518,594...46,621,919
Ensembl chr 1:46,518,709...46,633,687
|
|
G |
Synpr |
synaptoporin |
decreases expression |
EXP |
bromobenzene results in decreased expression of SYNPR mRNA |
CTD |
PMID:32479839 |
|
NCBI chr15:11,573,373...11,900,255
Ensembl chr15:11,574,231...11,900,243
|
|
G |
Sypl1 |
synaptophysin-like 1 |
increases expression |
EXP |
bromobenzene results in increased expression of SYPL1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:49,565,111...49,585,205
Ensembl chr 6:49,565,154...49,585,330
|
|
G |
Syt2 |
synaptotagmin 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of SYT2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:46,088,046...46,197,976
Ensembl chr13:46,185,282...46,193,859
|
|
G |
Taf9b |
TATA-box binding protein associated factor 9b |
increases expression |
EXP |
bromobenzene results in increased expression of TAF9B mRNA |
CTD |
PMID:12628495 |
|
NCBI chr X:71,289,290...71,300,142
Ensembl chr X:71,289,290...71,300,604
|
|
G |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of TANC1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:44,099,387...44,335,478
Ensembl chr 3:44,134,016...44,331,627
|
|
G |
Tat |
tyrosine aminotransferase |
increases expression |
EXP |
bromobenzene results in increased expression of TAT mRNA |
CTD |
PMID:32479839 |
|
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tbx3 |
T-box transcription factor 3 |
increases expression |
EXP |
bromobenzene results in increased expression of TBX3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708
|
|
G |
Tcea3 |
transcription elongation factor A3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TCEA3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:148,476,941...148,509,452
Ensembl chr 5:148,476,941...148,509,448
|
|
G |
Tcim |
transcriptional and immune response regulator |
increases expression |
EXP |
bromobenzene results in increased expression of TCIM mRNA |
CTD |
PMID:32479839 |
|
NCBI chr16:67,595,762...67,597,055
Ensembl chr16:67,593,410...67,597,581
|
|
G |
Tdrd1 |
tudor domain containing 1 |
increases expression |
EXP |
bromobenzene results in increased expression of TDRD1 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:255,871,939...255,919,222
Ensembl chr 1:255,875,887...255,915,871
|
|
G |
Tekt4 |
tektin 4 |
increases expression |
EXP |
bromobenzene results in increased expression of TEKT4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:14,487,760...14,492,936
Ensembl chr10:14,487,760...14,492,936
|
|
G |
Tenm2 |
teneurin transmembrane protein 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TENM2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr10:20,480,662...21,706,415
Ensembl chr10:20,481,854...21,705,597
|
|
G |
Tex36 |
testis expressed 36 |
increases expression |
EXP |
bromobenzene results in increased expression of TEX36 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:188,390,062...188,404,448
Ensembl chr 1:188,390,064...188,404,377
|
|
G |
Tex52 |
testis expressed 52 |
increases expression |
EXP |
bromobenzene results in increased expression of TEX52 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 4:161,651,232...161,663,250
Ensembl chr 4:161,638,816...161,660,540
|
|
G |
Tf |
transferrin |
decreases expression |
EXP |
bromobenzene results in decreased expression of TF mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tfcp2 |
transcription factor CP2 |
increases expression |
EXP |
bromobenzene results in increased expression of TFCP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:131,616,777...131,658,995
Ensembl chr 7:131,616,785...131,658,939
|
|
G |
Tg |
thyroglobulin |
decreases expression |
EXP |
bromobenzene results in decreased expression of TG mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
|
|
G |
Thbs4 |
thrombospondin 4 |
increases expression |
EXP |
bromobenzene results in increased expression of THBS4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 2:23,983,158...24,025,289
Ensembl chr 2:23,983,158...24,026,313
|
|
G |
Thra |
thyroid hormone receptor alpha |
decreases expression |
EXP |
bromobenzene results in decreased expression of THRA mRNA |
CTD |
PMID:15976192 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
EXP |
bromobenzene results in decreased expression of THRSP mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Thsd7b |
thrombospondin type 1 domain containing 7B |
increases expression |
EXP |
bromobenzene results in increased expression of THSD7B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:40,768,567...41,667,262
Ensembl chr13:40,768,570...41,666,501
|
|
G |
Timeless |
timeless circadian regulator |
decreases expression |
EXP |
bromobenzene results in decreased expression of TIMELESS mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
bromobenzene results in increased expression of TIMP1 mRNA |
CTD |
PMID:12628495 PMID:15056800 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tlr5 |
toll-like receptor 5 |
increases expression |
EXP |
bromobenzene results in increased expression of TLR5 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
|
|
G |
Tmem179 |
transmembrane protein 179 |
increases expression |
EXP |
bromobenzene results in increased expression of TMEM179 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:131,569,289...131,580,413
Ensembl chr 6:131,569,290...131,580,305
|
|
G |
Tmem252 |
transmembrane protein 252 |
increases expression |
EXP |
bromobenzene results in increased expression of TMEM252 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943
|
|
G |
Tmem26 |
transmembrane protein 26 |
increases expression |
EXP |
bromobenzene results in increased expression of TMEM26 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr20:19,820,768...19,872,561
Ensembl chr20:19,822,975...19,872,023
|
|
G |
Tmem30b |
transmembrane protein 30B |
increases expression |
EXP |
bromobenzene results in increased expression of TMEM30B mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:92,251,626...92,254,702
Ensembl chr 6:92,249,790...92,254,842
|
|
G |
Tmprss13 |
transmembrane serine protease 13 |
increases expression |
EXP |
bromobenzene results in increased expression of TMPRSS13 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:45,625,759...45,653,943
Ensembl chr 8:45,625,626...45,653,938
|
|
G |
Tmsb10 |
thymosin, beta 10 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TMSB10 mRNA |
CTD |
PMID:12628495 |
|
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
|
|
G |
Tnfaip2 |
TNF alpha induced protein 2 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TNFAIP2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
|
|
G |
Tnfaip8l3 |
TNF alpha induced protein 8 like 3 |
decreases expression |
EXP |
bromobenzene results in decreased expression of TNFAIP8L3 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 8:54,413,503...54,455,512
Ensembl chr 8:54,414,457...54,500,079
|
|
G |
Tnfrsf11a |
TNF receptor superfamily member 11A |
increases expression |
EXP |
bromobenzene results in increased expression of TNFRSF11A mRNA |
CTD |
PMID:32479839 |
|
NCBI chr13:21,928,370...21,986,719
Ensembl chr13:21,928,408...21,986,695
|
|
G |
Tnfrsf4 |
TNF receptor superfamily member 4 |
increases expression |
EXP |
bromobenzene results in increased expression of TNFRSF4 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 5:166,606,909...166,609,599
Ensembl chr 5:166,606,909...166,609,599
|
|
G |
Tnnc2 |
troponin C2, fast skeletal type |
increases expression |
EXP |
bromobenzene results in increased expression of TNNC2 mRNA |
CTD |
PMID:32479839 |
|
NCBI chr 3:153,513,272...153,516,033
Ensembl chr 3:153,513,271...153,516,029
|
| |